BMG Resources (ASX:BMG) Accelerates Gold Exploration in Western Australia
BMG Resources (ASX:BMG) accelerates gold exploration at Bullabulling and Invincible Projects, leveraging high-grade discoveries and strategic acquisitions.
Category: Companies
Austin Metals Limited (ASX:AYT) Announces $1.25M Capital Raising to Boost Exploration
Austin Metals Limited (ASX:AYT) raises $1.25M to enhance exploration at key WA gold and copper projects.
Prescient Therapeutics (ASX:PTX) Initiates Phase 2a PTX-100 Clinical Study
Prescient Therapeutics (ASX:PTX) initiates Phase 2a clinical study for PTX-100, marking a significant milestone in treating Cutaneous T-Cell Lymphoma.
AXP Energy Limited (ASX:AXP) Advances Second Gas-to-Power-Bitcoin Site
AXP Energy Limited (ASX:AXP) announces the scale-up of its second gas-to-power-bitcoin site, aiming for 25 MW/hr generation by CY2025.
Vanguard Investments Australia Ltd (ASX:VTS) Announces Final US Distribution
Vanguard Investments Australia Ltd (ASX:VTS) announces a final US distribution of $0.9854 per unit for CDI holders with key dates outlined.
Patriot Battery Metals Inc. (ASX:PMT) Discovers New Spodumene Pegmatite Cluster
Patriot Battery Metals Inc. (ASX:PMT) discovers the CV15 spodumene pegmatite cluster, significantly expanding the Mickel Trend at its Shaakichiuwaanaan Property.
Wildcat Resources Limited (ASX:WC8) Announces Strong Drilling Results for Lithium and Gold Projects
Wildcat Resources (ASX:WC8) reports robust drilling results at its Tabba Tabba Lithium and Mt Adrah Gold projects, underpinned by a strong financial position.
LTR Pharma Limited (ASX:LTP) Advances Multi-Market Strategy with FDA Milestone and Roxus Launch
LTR Pharma (ASX:LTP) achieves FDA approval path for SPONTAN and launches Roxus to accelerate US market entry.
4DMedical Limited (ASX:4DX) Announces $6.5m Annual Cost Reduction Program
4DMedical Limited (ASX:4DX) announces $6.5m annual cost reductions, supporting ongoing growth and key milestones.
Clinuvel (ASX:CUV) Announces Positive Preliminary Stroke Study Results
CLINUVEL (ASX:CUV) reports positive preliminary results from its latest stroke treatment study, highlighting high patient improvement rates.